Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Adenoviruses, Human | 3 | 2018 | 195 | 1.84 | Why? |
| Adenovirus Infections, Human | 3 | 2018 | 145 | 1.37 | Why? |
| Keratoconjunctivitis | 1 | 2018 | 41 | 0.71 | Why? |
| Adenoviridae Infections | 1 | 2018 | 150 | 0.66 | Why? |
| Paralysis | 1 | 2017 | 92 | 0.66 | Why? |
| Adenoidectomy | 1 | 2016 | 41 | 0.64 | Why? |
| Arm | 1 | 2017 | 159 | 0.64 | Why? |
| Lymphadenitis | 1 | 2016 | 53 | 0.63 | Why? |
| Tonsillitis | 1 | 2016 | 67 | 0.59 | Why? |
| Tonsillectomy | 1 | 2016 | 115 | 0.58 | Why? |
| Airway Obstruction | 1 | 2016 | 182 | 0.54 | Why? |
| Sleep Apnea Syndromes | 1 | 2016 | 282 | 0.49 | Why? |
| New York | 6 | 2021 | 2488 | 0.40 | Why? |
| Specimen Handling | 3 | 2021 | 6190 | 0.35 | Why? |
| Biodiversity | 1 | 2011 | 546 | 0.33 | Why? |
| Oseltamivir | 1 | 2011 | 583 | 0.32 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.32 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.28 | Why? |
| Drug Resistance, Viral | 1 | 2011 | 1083 | 0.27 | Why? |
| Clinical Laboratory Techniques | 6 | 2021 | 23402 | 0.25 | Why? |
| Influenza, Human | 5 | 2021 | 10779 | 0.25 | Why? |
| Molecular Epidemiology | 2 | 2018 | 1638 | 0.23 | Why? |
| High-Throughput Screening Assays | 1 | 2020 | 1783 | 0.22 | Why? |
| Zika Virus | 3 | 2018 | 1924 | 0.21 | Why? |
| Diagnostic Test Approval | 1 | 2020 | 35 | 0.21 | Why? |
| Zika Virus Infection | 3 | 2018 | 1920 | 0.20 | Why? |
| Virus Diseases | 1 | 2016 | 3779 | 0.19 | Why? |
| Influenza A Virus, H7N2 Subtype | 1 | 2017 | 11 | 0.18 | Why? |
| New England | 1 | 2018 | 143 | 0.18 | Why? |
| Asymptomatic Infections | 1 | 2016 | 7218 | 0.17 | Why? |
| Adenoids | 1 | 2016 | 21 | 0.17 | Why? |
| Hypertrophy | 1 | 2016 | 86 | 0.16 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.16 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.16 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 2984 | 0.15 | Why? |
| Palatine Tonsil | 1 | 2016 | 127 | 0.15 | Why? |
| Genome, Viral | 4 | 2018 | 13157 | 0.15 | Why? |
| Disease Outbreaks | 3 | 2018 | 27595 | 0.15 | Why? |
| Product Surveillance, Postmarketing | 1 | 2017 | 189 | 0.14 | Why? |
| Fetus | 1 | 2017 | 484 | 0.13 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2017 | 511 | 0.13 | Why? |
| Paramyxoviridae Infections | 1 | 2016 | 364 | 0.13 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.12 | Why? |
| Epstein-Barr Virus Infections | 1 | 2016 | 366 | 0.12 | Why? |
| Influenza in Birds | 1 | 2017 | 528 | 0.12 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.11 | Why? |
| Enterovirus Infections | 1 | 2016 | 404 | 0.11 | Why? |
| Cat Diseases | 1 | 2017 | 539 | 0.11 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.11 | Why? |
| Picornaviridae Infections | 1 | 2016 | 544 | 0.11 | Why? |
| Temperature | 1 | 2021 | 2305 | 0.11 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.10 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.10 | Why? |
| Sequence Homology | 1 | 2011 | 448 | 0.10 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.09 | Why? |
| Infant | 4 | 2020 | 30274 | 0.09 | Why? |
| Automation, Laboratory | 1 | 2020 | 536 | 0.08 | Why? |
| Serologic Tests | 2 | 2020 | 4359 | 0.08 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.08 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2016 | 1234 | 0.08 | Why? |
| Placenta | 1 | 2017 | 1531 | 0.08 | Why? |
| New York City | 3 | 2021 | 7432 | 0.08 | Why? |
| Humans | 21 | 2021 | 930598 | 0.07 | Why? |
| Phylogeny | 2 | 2017 | 13341 | 0.07 | Why? |
| Polymerase Chain Reaction | 2 | 2020 | 6740 | 0.07 | Why? |
| Molecular Sequence Data | 1 | 2011 | 3198 | 0.07 | Why? |
| Laboratories | 2 | 2021 | 2858 | 0.07 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.06 | Why? |
| Zoonoses | 1 | 2017 | 3034 | 0.06 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.06 | Why? |
| Symptom Assessment | 1 | 2017 | 4967 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| RNA, Viral | 5 | 2020 | 32276 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Pregnancy Complications, Infectious | 2 | 2018 | 11559 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Child | 4 | 2020 | 70012 | 0.05 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.05 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.05 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.05 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.05 | Why? |
| Genotype | 1 | 2011 | 4697 | 0.05 | Why? |
| United States | 4 | 2021 | 46150 | 0.05 | Why? |
| Housing, Animal | 1 | 2017 | 53 | 0.05 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Antiviral Agents | 1 | 2011 | 41703 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Veterinarians | 1 | 2017 | 49 | 0.04 | Why? |
| Immunoglobulin M | 3 | 2020 | 9091 | 0.04 | Why? |
| Protein Conformation, beta-Strand | 1 | 2017 | 414 | 0.04 | Why? |
| District of Columbia | 1 | 2017 | 343 | 0.04 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2017 | 530 | 0.04 | Why? |
| Birds | 1 | 2017 | 412 | 0.04 | Why? |
| Spatial Analysis | 1 | 2020 | 878 | 0.03 | Why? |
| Male | 6 | 2021 | 367725 | 0.03 | Why? |
| Immunocompromised Host | 1 | 2011 | 5150 | 0.03 | Why? |
| Adult | 4 | 2020 | 244371 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.03 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2005 | 3388 | 0.03 | Why? |
| Prospective Studies | 1 | 2016 | 43301 | 0.03 | Why? |
| Cats | 1 | 2017 | 1890 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2017 | 2134 | 0.03 | Why? |
| Polysaccharides | 1 | 2017 | 854 | 0.03 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Health Personnel | 1 | 2018 | 29646 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Cross Reactions | 1 | 2018 | 4374 | 0.02 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.02 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.02 | Why? |
| Neutralization Tests | 1 | 2018 | 6698 | 0.02 | Why? |
| Models, Molecular | 1 | 2017 | 7616 | 0.02 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.01 | Why? |
| SARS Virus | 1 | 2005 | 13021 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2005 | 12361 | 0.01 | Why? |
| Antibodies, Viral | 3 | 2020 | 51949 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Receptors, Virus | 1 | 2017 | 5659 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Middle Aged | 2 | 2020 | 270681 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2018 | 25288 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 13720 | 0.00 | Why? |
| Aged | 1 | 2020 | 215776 | 0.00 | Why? |
St George's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(191)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_